ConductScience.org, home

Paper26319488

The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.

Samson P and 12 others. Ann Thorac Surg, 2015. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis. Papers, record 26319488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26319488

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.
PubMed
Journal
Ann Thorac Surg
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2018-11-13
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Samson PPamela
2Patel AAalok
3Robinson CGCliff G
4Morgensztern DDaniel
5Chang SHSu-Hsin
6Colditz GAGraham A
7Waqar SSaiama
8Crabtree TDTraves D
9Krupnick ASA Sasha
10Kreisel DDaniel
11Patterson GAG Alexander
12Meyers BFBryan F
13Puri VVarun

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Health Care CostsMajor topic
Lung NeoplasmsMajor topic
Neoplasm StagingMajor topic
PneumonectomyMajor topic
Cost-Benefit Analysis
Humans
Retrospective Studies

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K12-CA-167540-02NCI NIH HHSUnited StatesK12CA167540PubMed and NIHNIH RePORTER
T32 CA009621NCI NIH HHSUnited StatesT32CA009621PubMed and NIHNIH RePORTER
K12 CA167540NCI NIH HHSUnited StatesK12CA167540PubMed and NIHNIH RePORTER
T32-CA-009621-25NCI NIH HHSUnited StatesT32CA009621PubMed and NIHNIH RePORTER
K07 CA178120NCI NIH HHSUnited StatesK07CA178120PubMed and NIHNIH RePORTER
P30 CA091842NCI NIH HHSUnited StatesP30CA091842PubMed and NIHNIH RePORTER
T32 HL007776NHLBI NIH HHSUnited StatesT32HL007776PubMed and NIHNIH RePORTER
K07-CA-178120NCI NIH HHSUnited StatesK07CA178120PubMed and NIHNIH RePORTER

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115908042
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Lung Cancer2005https://conductscience.org/library/papers/15908042PubMed
212243809
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
Int J Radiat Oncol Biol Phys2002https://conductscience.org/library/papers/12243809PubMed
317356099Updated evaluation of the cost-effectiveness of lung volume reduction surgery.Chest2007https://conductscience.org/library/papers/17356099PubMed
422169443A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.J Thorac Cardiovasc Surg2012https://conductscience.org/library/papers/22169443PubMed
518831506Cost comparison of robotic, video-assisted thoracic surgery and thoracotomy approaches to pulmonary lobectomy.Thorac Surg Clin2008https://conductscience.org/library/papers/18831506PubMed
614688709Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis.J Thorac Cardiovasc Surg2003https://conductscience.org/library/papers/14688709PubMed
719551884Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.Cancer2009https://conductscience.org/library/papers/19551884PubMed
819875976Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.J Thorac Oncol2009https://conductscience.org/library/papers/19875976PubMed
919803556Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.J Manag Care Pharm2009https://conductscience.org/library/papers/19803556PubMed
1022386614Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality.Heart Lung Circ2012https://conductscience.org/library/papers/22386614PubMed
117497767The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group.Chest1995https://conductscience.org/library/papers/7497767PubMed
1211064351High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma.Cancer2000https://conductscience.org/library/papers/11064351PubMed
1323720093Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.Cancer2013https://conductscience.org/library/papers/23720093PubMed
1424210834Comparing robot-assisted thoracic surgical lobectomy with conventional video-assisted thoracic surgical lobectomy and wedge resection: results from a multihospital database (Premier).J Thorac Cardiovasc Surg2014https://conductscience.org/library/papers/24210834PubMed
1524018022Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.Lung Cancer2013https://conductscience.org/library/papers/24018022PubMed
1619049763Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.Ann Thorac Surg2008https://conductscience.org/library/papers/19049763PubMed
1725439468Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes.J Thorac Cardiovasc Surg2015https://conductscience.org/library/papers/25439468PubMed
1821228314Projections of the cost of cancer care in the United States: 2010-2020.J Natl Cancer Inst2011https://conductscience.org/library/papers/21228314PubMed
1925085960
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Circulation2014https://conductscience.org/library/papers/25085960PubMed
2019632716Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.Lancet2009https://conductscience.org/library/papers/19632716PubMed

See all 34 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
38505073Surgical-decision making in the setting of unsuspected N2 disease: a cost-effectiveness analysis.J Thorac Dis2024https://conductscience.org/library/papers/38505073PubMed
37624518Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based Study.Ann Surg Oncol2023https://conductscience.org/library/papers/37624518PubMed
36378625The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study.PLoS One2022https://conductscience.org/library/papers/36378625PubMed
36004217Select octogenarians with stage IIIa non-small cell lung cancer can benefit from trimodality therapy.JTCVS Open2022https://conductscience.org/library/papers/36004217PubMed
35687964Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities.Curr Probl Cancer2022https://conductscience.org/library/papers/35687964PubMed
33014826Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer.Front Oncol2020https://conductscience.org/library/papers/33014826PubMed
28964421A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients.Ann Thorac Surg2017https://conductscience.org/library/papers/28964421PubMed
27844308Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.J Neurooncol2017https://conductscience.org/library/papers/27844308PubMed
27293147Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival.Ann Thorac Surg2016https://conductscience.org/library/papers/27293147PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26319488

GET https://conductscience.org/api/papers/v1/26319488/references?page=2